A Study Examining Maintenance Bevacizumab (Avastin®) Monotherapy in Participants With Advanced Lung Adenocarcinoma

Clinical trial NCT02093000 · COMPLETED

Trial details

NCT number: NCT02093000
Sponsor: Hoffmann-La Roche
Status: COMPLETED
Study type: OBSERVATIONAL

Lung Adenocarcinoma

Start date: 2014-11-30
Primary completion: 2018-01-31
Enrollment: 201

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.